Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
What is This Site Help Center Crisis
Powered By

Top 6 search results for "Tarceva" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
NSCLC Targeted Therapy: 8 Facts
... Targeted Therapies Approved for Use in NSCLC Class of Targeted Therapy Targeted Therapy Drugs KRAS inhibitors Adagrasib (Krazati) Sotorasib (Lumakras) EGFR inhibitors Afatinib (Gilotrif) Amivantamab (Rybrevant) Dacomitinib (Vizimpro) Erlotinib (Tarceva) Gefitinib (Iressa) Lazertinib (Lazcluze) Necitumumab (Portrazza) Osimertinib (Tagresso) ...
NSCLC Targeted Therapy: 8 Facts
... Targeted Therapies Approved for Use in NSCLC Class of Targeted Therapy Targeted Therapy Drugs KRAS inhibitors Adagrasib (Krazati) Sotorasib (Lumakras) EGFR inhibitors Afatinib (Gilotrif) Amivantamab (Rybrevant) Dacomitinib (Vizimpro) Erlotinib (Tarceva) Gefitinib (Iressa) Lazertinib (Lazcluze) Necitumumab (Portrazza) Osimertinib (Tagresso) ...
Clinical Trials for NSCLC: What To Ask Your Doctor
... References Recent Advances in the Management of Lung Cancer — Clinical Medicine (London) FDA Drug Approval Summary: Erlotinib (Tarceva) Tablets — The Oncologist FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non‐Small Cell Lung Cancer: First‐Line Therapy and Beyond — The Oncologist Recent Advances in Lung Cancer Treatment Resulting ...
Clinical Trials for NSCLC: What To Ask Your Doctor
... References Recent Advances in the Management of Lung Cancer — Clinical Medicine (London) FDA Drug Approval Summary: Erlotinib (Tarceva) Tablets — The Oncologist FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non‐Small Cell Lung Cancer: First‐Line Therapy and Beyond — The Oncologist Recent Advances in Lung Cancer Treatment Resulting ...
Biomarkers for Lung Cancer: 12 Things To Know
... These mutations help cancer cells grow and divide.Several FDA-approved treatments are available for NSCLC tumors with EGFR mutations, including: Afatinib (Gilotrif) Dacomitinib (Vizimpro) Erlotinib (Tarceva) Gefitinib (Iressa) Necitumumab (Portrazza) Osimertinib (Tagrisso) Ramucirumab (Cyramza) Sunvozertinib (Zegfrovy) Some EGFR Treatments Depend on ...
Biomarkers for Lung Cancer: 12 Things To Know
... These mutations help cancer cells grow and divide.Several FDA-approved treatments are available for NSCLC tumors with EGFR mutations, including: Afatinib (Gilotrif) Dacomitinib (Vizimpro) Erlotinib (Tarceva) Gefitinib (Iressa) Necitumumab (Portrazza) Osimertinib (Tagrisso) Ramucirumab (Cyramza) Sunvozertinib (Zegfrovy) Some EGFR Treatments Depend on ...
6 Lung Cancer Mutations and Treatments That Target Them
... Food and Drug Administration (FDA) for lung cancers containing EGFR mutations: Erlotinib (Tarceva) Gefitinib (Iressa) Afatinib (Gilotrif) Dacomitinib (Vizimpro) Osimertinib (Tagrisso) You can learn more about these medications and other treatments for lung cancer here.2. ...
6 Lung Cancer Mutations and Treatments That Target Them
... Food and Drug Administration (FDA) for lung cancers containing EGFR mutations: Erlotinib (Tarceva) Gefitinib (Iressa) Afatinib (Gilotrif) Dacomitinib (Vizimpro) Osimertinib (Tagrisso) You can learn more about these medications and other treatments for lung cancer here.2. ...
EGFR-Positive Lung Cancer: 5 Facts To Know
... These are known as first-generation TKIs and include the drugs erlotinib (Tarceva) and gefitinib (Iressa). First-generation TKIs are used to treat people with EGFR mutations in exon 19 or 21. ...
EGFR-Positive Lung Cancer: 5 Facts To Know
... These are known as first-generation TKIs and include the drugs erlotinib (Tarceva) and gefitinib (Iressa). First-generation TKIs are used to treat people with EGFR mutations in exon 19 or 21. ...
Posttreatment Lung Cancer Rash: Photos and Tips To Soothe
... Treatment — Cancer Management and Research Radiation Dermatitis: An Overview — International Journal of Dermatology Acute and Chronic Cutaneous Reactions to Ionizing Radiation Therapy — Dermatology and Therapy Chemotherapy and Skin Reactions — Journal of Experimental & Clinical Cancer Research Acneiform Rash During Lung Cancer Therapy With Erlotinib (Tarceva ...
Posttreatment Lung Cancer Rash: Photos and Tips To Soothe
... Treatment — Cancer Management and Research Radiation Dermatitis: An Overview — International Journal of Dermatology Acute and Chronic Cutaneous Reactions to Ionizing Radiation Therapy — Dermatology and Therapy Chemotherapy and Skin Reactions — Journal of Experimental & Clinical Cancer Research Acneiform Rash During Lung Cancer Therapy With Erlotinib (Tarceva ...